Tumoral Calcinosis. Observations during Six Years
| Autor: | Seeliger H, Leicht E, H. G. Haas, Tkocz Hj, Lauffenburger T |
|---|---|
| Rok vydání: | 1980 |
| Předmět: |
Very low-density lipoprotein
medicine.medical_specialty Nephrotic Syndrome Biopsy Endocrinology Diabetes and Metabolism Clinical Biochemistry Lipoproteins VLDL Biochemistry Gastroenterology High cholesterol Endocrinology Internal medicine Humans Medicine Histiocyte Tumor size business.industry Amyloidosis Biochemistry (medical) Calcinosis Etidronic Acid General Medicine Middle Aged medicine.disease Hypercalcemia Tumor reduction Tumoral calcinosis Female business Nephrotic syndrome |
| Zdroj: | Hormone and Metabolic Research. 12:269-273 |
| ISSN: | 1439-4286 0018-5043 |
| DOI: | 10.1055/s-2007-996264 |
| Popis: | Findings of a 56 year old woman suffering from tumoral calcinosis, who was treated for 6 years, are presented. Under conditions known to lead to negative calcium-phosphorus balance, a reduction in tumor size was seen. Transient hypercalcemia was attributed to immobilization. The process of tumor reduction was not definitely accelerated by treatment with ethane-hydroxy-diphosphonate (EHDP; 500 mg/day for 20 months). Nephrotic syndrome as a consequence of amyloidosis developed. Amyloidosis seems to have resulted from the aseptic histiocytic inflammatory process in the tumors. The possible importance of high cholesterol in very low density lipoproteins in the serum of the patient is discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|